These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 873093)
1. B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment. Faber OK; Binder C Diabetologia; 1977 May; 13(3):263-8. PubMed ID: 873093 [TBL] [Abstract][Full Text] [Related]
2. Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function. Madsbad S; Faber OK; Binder C; Alberti KG; Lloyd B Acta Diabetol Lat; 1981; 18(2):115-21. PubMed ID: 7018146 [TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. Polonsky KS; Given BD; Van Cauter E J Clin Invest; 1988 Feb; 81(2):442-8. PubMed ID: 3276730 [TBL] [Abstract][Full Text] [Related]
4. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267 [TBL] [Abstract][Full Text] [Related]
5. Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics. Madsbad S; Krarup T; Reguer L; Faber OK; Binder C Diabetologia; 1981 May; 20(5):530-4. PubMed ID: 7026327 [TBL] [Abstract][Full Text] [Related]
7. Abnormalities of endogenous glucagon and insulin in unstable diabetes. Reynolds C; Molnar GD; Horwitz DL; Rubenstein AH; Taylor WF; Jiang NS Diabetes; 1977 Jan; 26(1):36-45. PubMed ID: 830563 [TBL] [Abstract][Full Text] [Related]
8. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Faber OK; Binder C Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604 [TBL] [Abstract][Full Text] [Related]
9. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the 24-hour profiles of physiological insulin, glucose, and C-peptide in healthy Japanese volunteers. Tsukuda K; Kikuchi M; Irie S; Eto T; Yamada A; Matsuguma K; Sasaki T; Katayama Y Diabetes Technol Ther; 2009 Aug; 11(8):499-508. PubMed ID: 19698063 [TBL] [Abstract][Full Text] [Related]
12. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects. Prince RL; Larkins RG; Alford FP Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074 [No Abstract] [Full Text] [Related]
13. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896 [TBL] [Abstract][Full Text] [Related]
14. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes. Lutterman JA; Benraad TJ; van 't Laar A Diabetologia; 1981 Aug; 21(2):99-102. PubMed ID: 7021291 [TBL] [Abstract][Full Text] [Related]
15. Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment. Madsbad S; Krarup T; Regeur L; Faber OK; Binder C Acta Endocrinol (Copenh); 1980 Nov; 95(3):359-63. PubMed ID: 7001832 [TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects. Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972 [TBL] [Abstract][Full Text] [Related]
17. Plasma C-peptide response to oral glucose in low insulin responders, subdiabetic, and diabetic subjects. Toyota T; Kudo M; Abe K; Goto Y Tohoku J Exp Med; 1977 Feb; 121(2):99-104. PubMed ID: 847746 [TBL] [Abstract][Full Text] [Related]
18. Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics. Hidaka H; Nagulesparan M; Klimes I; Clark R; Sasaki H; Aronoff SL; Vasquez B; Rubenstein AH; Unger RH J Clin Endocrinol Metab; 1982 Feb; 54(2):217-22. PubMed ID: 7033272 [TBL] [Abstract][Full Text] [Related]
19. Effect of diabetes mellitus and insulin on the turnover and metabolic response to ketones in man. Sherwin RS; Hendler RG; Felig P Diabetes; 1976 Sep; 25(9):776-84. PubMed ID: 955305 [TBL] [Abstract][Full Text] [Related]
20. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man. Hanna AK; Zinman B; Nakhooda AF; Minuk HL; Stokes EF; Albisser AM; Leibel BS; Marliss EB Metabolism; 1980 Apr; 29(4):321-32. PubMed ID: 6990172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]